Literature DB >> 21130367

Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes.

Lynne E Wagenknecht1, Jasmin Divers, Alain G Bertoni, Carl D Langefeld, J Jeffrey Carr, Donald W Bowden, Steven C Elbein, Steven Shea, Cora E Lewis, Barry I Freedman.   

Abstract

PURPOSE: To examine whether the relationship between cardiovascular disease risk factors and coronary artery calcification (CAC) is modified by race among those with diabetes.
METHODS: Data were pooled data from three studies (Multi-Ethnic Study of Atherosclerosis, Family Heart Study, Diabetes Heart Study) for a total of 835 blacks and 1122 whites with diabetes. CAC was quantified by cardiac computed tomography and risk factors were obtained using standard methods. Regression models examined the relationship between risk factors and presence and quantity of CAC.
RESULTS: The average age of the cohort was 60 years; 57% were women. Presence of CAC was lower in blacks compared to whites (odds ratio = 0.22 for men, 0.57 for women, p <0.01). Hemoglobin A1c, duration of diabetes, low-density lipoprotein, smoking, and body mass index were independently associated with presence of CAC; high-density lipoprotein, triglycerides, and C-reactive protein were not. Race did not modify these associations. Adjustment for multiple risk factors did not explain the race disparity in CAC.
CONCLUSIONS: CAC was reduced in blacks compared to whites in persons with diabetes. This effect was most pronounced in men. The relationship between risk factors and CAC did not differ between races. Racial differences in CAC are likely due to unmeasured risk factors and/or genetic susceptibility.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21130367      PMCID: PMC3026318          DOI: 10.1016/j.annepidem.2010.10.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  38 in total

1.  The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Matthew A Allison; Michael H Criqui; Robyn L McClelland; JoAnn M Scott; Mary M McDermott; Kiang Liu; Aaron R Folsom; Alain G Bertoni; A Richey Sharrett; Shunichi Homma; Sujata Kori
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Coronary artery calcification in black women and white women.

Authors:  Charanjit Khurana; Christina G Rosenbaum; Barbara V Howard; Lucile L Adams-Campbell; Robert C Detrano; Afifa Klouj; Judith Hsia
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

3.  Racial differences in coronary artery calcification in older adults.

Authors:  Anne B Newman; Barbara L Naydeck; Jeff Whittle; Kim Sutton-Tyrrell; Daniel Edmundowicz; Lewis H Kuller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

Review 4.  Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis.

Authors:  H D Intengan; E L Schiffrin
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

5.  NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network.

Authors:  R R Williams; D C Rao; R C Ellison; D K Arnett; G Heiss; A Oberman; J H Eckfeldt; M F Leppert; M A Province; S C Mockrin; S C Hunt
Journal:  Ann Epidemiol       Date:  2000-08       Impact factor: 3.797

6.  Conventional coronary artery disease risk factors and coronary artery calcium detected by electron beam tomography in 30,908 healthy individuals.

Authors:  Julie Anne Hoff; Martha L Daviglus; Eva V Chomka; Andrew J Krainik; Alexander Sevrukov; George T Kondos
Journal:  Ann Epidemiol       Date:  2003-03       Impact factor: 3.797

7.  The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects.

Authors:  Timothy C Lee; Patrick G O'Malley; Irwin Feuerstein; Allen J Taylor
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

8.  C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Michelle J Kupka; Warren J Manning; Melvin E Clouse; Ralph B D'Agostino; Peter W F Wilson; Christopher J O'Donnell
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

9.  Prognostic value of coronary artery calcium screening in subjects with and without diabetes.

Authors:  Paolo Raggi; Leslee J Shaw; Daniel S Berman; Tracy Q Callister
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  12 in total

1.  The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study.

Authors:  Christina E Hugenschmidt; Fang-Chi Hsu; Satoru Hayasaka; J Jeffrey Carr; Barry I Freedman; David L Nyenhuis; Jeff D Williamson; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2013-05-07       Impact factor: 2.852

Review 2.  Diabetes and Clinical and Subclinical CVD.

Authors:  Alain G Bertoni; Holly Kramer; Karol Watson; Wendy S Post
Journal:  Glob Heart       Date:  2016-09

3.  Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus.

Authors:  Jasmin Divers; Nicholette D Palmer; Lingyi Lu; Thomas C Register; J Jeffrey Carr; Pamela J Hicks; R Caresse Hightower; S Carrie Smith; Jianzhao Xu; Amanda J Cox; Keith A Hruska; Donald W Bowden; Cora E Lewis; Gerardo Heiss; Michael A Province; Ingrid B Borecki; Kathleen F Kerr; Y-D Ida Chen; Walter Palmas; Jerome I Rotter; Christina L Wassel; Alain G Bertoni; David M Herrington; Lynne E Wagenknecht; Carl D Langefeld; Barry I Freedman
Journal:  Circ Cardiovasc Genet       Date:  2012-12-11

Review 4.  Effect of race and genetics on vitamin D metabolism, bone and vascular health.

Authors:  Barry I Freedman; Thomas C Register
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

5.  Ethnic differences in the development of albuminuria: the DISTANCE study.

Authors:  Andy I Choi; Andrew J Karter; Jennifer Y Liu; Bessie A Young; Alan S Go; Dean Schillinger
Journal:  Am J Manag Care       Date:  2011-11       Impact factor: 2.229

6.  Vitamin D Associations With Renal, Bone, and Cardiovascular Phenotypes: African American-Diabetes Heart Study.

Authors:  Barry I Freedman; Jasmin Divers; Gregory B Russell; Nicholette D Palmer; Lynne E Wagenknecht; S Carrie Smith; Jianzhao Xu; J Jeffrey Carr; Donald W Bowden; Thomas C Register
Journal:  J Clin Endocrinol Metab       Date:  2015-07-21       Impact factor: 5.958

7.  Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study.

Authors:  Vanessa Xanthakis; Jung Hye Sung; Tandaw E Samdarshi; Alethea N Hill; Solomon K Musani; Mario Sims; Kamel A Ghraibeh; Philip R Liebson; Herman A Taylor; Ramachandran S Vasan; Ervin R Fox
Journal:  Diabetes Care       Date:  2015-03-12       Impact factor: 19.112

Review 8.  Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures.

Authors:  Barry I Freedman; Jasmin Divers; Nicholette D Palmer
Journal:  Am J Kidney Dis       Date:  2013-07-26       Impact factor: 8.860

9.  APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.

Authors:  Orlando M Gutiérrez; Sophie Limou; Feng Lin; Carmen A Peralta; Holly J Kramer; J Jeffrey Carr; Kirsten Bibbins-Domingo; Cheryl A Winkler; Cora E Lewis; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2017-10-14       Impact factor: 18.998

10.  Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.

Authors:  Mariana Murea; Thomas C Register; Jasmin Divers; Donald W Bowden; J Jeffrey Carr; Caresse R Hightower; Jianzhao Xu; S Carrie Smith; Keith A Hruska; Carl D Langefeld; Barry I Freedman
Journal:  BMC Nephrol       Date:  2012-11-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.